siRNA, Anti-SLC9A1, 2'-F/2'-OMe/2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT21258WQ-2OMe)

The product SIRGT21258WQ-2OMe is a type of small interfering RNA (siRNA) that targets SLC9A1 gene and regulates the expression of gene. The siRNA interferes with the expression of SLC9A1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_003047.4
Alternative Names APNH; LIKNS; NHE-1; NHE1; PPP1R143
Related Diseases Lichtenstein-Knorr Syndrome, Myocardial Stunning
Purification HPLC
Target Gene
Gene ID 6548
Uniprot ID P19634
Sub Cat Target Species Modification Scale  
SIRGT22258WQ-2F SLC9A1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT23258WQ-2MOE SLC9A1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT21258WQ-RB SLC9A1 Human Ribo-modified Inquiry
SIRGT22258WQ-BB SLC9A1 Human Backbone-modified Inquiry

Related Products